Nafloxin (Ciprofloxacin Hydrochloride)

Ciprofloxacin Hydrochloride, the active ingredient in Nafloxin, is a fluoroquinolone antibiotic presented as an ophthalmic preparation for ocular use. It treats bacterial conjunctivitis, keratitis and other ocular bacterial infections in patients requiring topical therapy.

GNH USA supplies Nafloxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nafloxin is a fluoroquinolone antibiotic used to manage bacterial infections of the eye and related structures. - Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Keratitis: eradicates causative bacteria, promoting corneal healing and visual recovery. - Other ocular bacterial infections: treats infections such as blepharitis or postoperative bacterial inflammation, helping to prevent complications.

Adverse reactions may occur with any ophthalmic antibiotic. Most are mild and resolve after discontinuation.

Common Side Effects: - Stinging or burning sensation upon instillation. - Redness of the conjunctiva. - Temporary blurred vision. - Eyelid edema or itching. - Mild ocular irritation.

Serious or Rare Side Effects: - Allergic contact dermatitis or severe hypersensitivity. - Corneal ulceration or perforation. - Tendon rupture (systemic exposure). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vision loss due to severe ocular inflammation.

Before prescribing Nafloxin, clinicians should consider patient‑specific factors and safety measures. - Allergy assessment: verify no known hypersensitivity to fluoroquinolones or ophthalmic excipients. - Infection type: avoid use for viral, fungal or allergic conjunctivitis. - Corneal integrity: use with caution in patients with epithelial defects or recent corneal surgery. - Concomitant steroids: monitor closely as steroids may delay wound healing. - Contact lens wear: advise removal of lenses during treatment. - Store at room temperature: keep in original container, protect from moisture and light.

Ciprofloxacin ophthalmic solutions can interact with systemic or ocular agents, influencing safety or efficacy.

Major Interactions (Avoid): - Systemic fluoroquinolones: cumulative toxicity, especially tendon or CNS effects. - Oral antacids or supplements containing magnesium/aluminum: may increase systemic exposure if absorbed. - Warfarin: potential enhancement of anticoagulant effect. - Corticosteroid eye drops: increased risk of delayed corneal healing.

Moderate Interactions (Monitor Closely): - Other topical antibiotics: possible antagonism or reduced efficacy. - Non‑steroidal anti‑inflammatory eye drops: monitor for ocular irritation. - Tetracycline eye ointments: assess for additive photosensitivity. - Systemic NSAIDs: watch for tendon‑related adverse events.